Latest Breaking News On - Burak zeybeck - Page 1 : comparemela.com

Burak Zeybeck, MD, discusses key results and clinical implications from the phase 1 NOW trial investigating neoadjuvant olaparib in patients with newly diagnosed, BRCA-mutant ovarian cancer.

Burak zeybeckUniversity of florida school medicineFlorida schoolNeoadjuvant olaparibAdjuvant chemotherapySurgical resectionBrca mutationNewly diagnosed ovarian cancerHase 1 now trial